Integrating New Technology into Blood Plasma Fractionation

by John Curling, ProMetic BioSciences Ltd. Immune serum globulin is in high demand, and that demand will only increase. Yet despite product shortages, the complexities involved in creating new manufacturing processes discourage change. The benefits - increased yield, reduced costs, new technologies, and faster throughput - now make identifying the best place in the processing stream to make manufacturing changes a rewrding endeavor. Planned change always trumps losing market share or being forced to change by new regulations.

Related Content:

Retrovirus and Parvovirus Clearance from an Affinity Column Product Using Adsorptive Depth Filtration

Reexamining the Set It and Forget It Approach

Controlled Clean Environment Enclosures: A Cost-Effective Alternative to Cleanrooms